logo
ProjectForthcoming

Oligonucleotide Backbone Modifications

Sector: Education • Location: Switzerland

Source: EU Funding & Tenders Portal

Therapeutic oligonucleotides are rapidly emerging as novel modalities for the treatment of several previously unaddressable diseases. The development of oligonucleotide therapeutics has thereby been significantly driven by chemical modifications that enhance nuclease resistance, pharmacokinetic properties, and target engagement. Especially the modification of the phosphorus site at the internucleo

Status
Prospective
Sector
Education, Chemical (Industrial), Manufacturing (Industrial)
Location
Switzerland
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Oligonucleotide Backbone Modifications

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Oligonucleotide Backbone Modifications” is an infrastructure initiative in the Education sector, located in Switzerland. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Therapeutic oligonucleotides are rapidly emerging as novel modalities for the treatment of several previously unaddressable diseases. The development of oligonucleotide therapeutics has thereby been significantly driven by chemical modifications that enhance nuclease resistance, pharmacokinetic properties, and target engagement. Especially the modification of the phosphorus site at the internucleoside linkage, in particular by the replacement of an oxygen with sulfur in the form of phosphorothioates, proved to be decisively beneficial. However, despite the immense and immediate impact, the current phosphorus backbone chemistry to form modified functionalities, such as phosphonates and phosphoramidates, remained severely limited by the classical reactivity at phosphorus. Expanding the chemical space of oligonucleotide backbone modifications requires transformations that can operate under mild conditions compatible with sensitive nucleic acid substrates. Here, we propose to explore the innovation potential of an unusually versatile method for oligonucleotide backbone modification developed in the framework of an ERC-CoG funded project. With the intellectual property protected by the filing of four patent applications, this Proof of Concept project aims to explore a stereoselective library creation by the divergent synthetic backbone modification platform. The method already allows linear and parallel synthesis from commercially available nucleosides via standard phosphoramidite synthesis and avoids the purification of sensitive intermediates. Efforts in this PoC will be focussed on diastereoselective oligonucleotide backbone modifications, the corresponding IP protection, licensing of the innovation as part of research collaborations with the pharmaceutical industry, and the creation of a spinout company.

Location

Country

Switzerland

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Education, Chemical (Industrial), Manufacturing (Industrial)

Article published date

2026-09-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project